SOLENO THERAPEUTICS INC Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Soleno Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Soleno Therapeutics Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$80.2M, a 673% decline year-over-year.
  • Soleno Therapeutics Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$142M, a 331% decline year-over-year.
  • Soleno Therapeutics Inc annual Operating Income (Loss) for 2023 was -$41.4M, a 69.6% decline from 2022.
  • Soleno Therapeutics Inc annual Operating Income (Loss) for 2022 was -$24.4M, a 22.6% increase from 2021.
  • Soleno Therapeutics Inc annual Operating Income (Loss) for 2021 was -$31.5M, a 13.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$41.4M -$17M -69.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$24.4M +$7.13M +22.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$31.5M +$4.76M +13.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$36.3M -$12.8M -54.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$23.5M -$9.19M -64.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-03
2018 -$14.3M -$2.13M -17.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-04
2017 -$12.2M -$3.85M -46.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-20
2016 -$8.32M +$3.84M +31.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 -$12.2M -$7M -136% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-15
2014 -$5.16M -$4.31M -509% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-25
2013 -$847K Jan 1, 2013 Dec 31, 2013 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.